DUBLIN, Ireland and MELBOURNE, Australia, May 11, 2015 (GLOBE NEWSWIRE) Link here. Nexvet Biopharma (Nasdaq:NVET), a veterinary biologic therapy developer, today announced it has appointed former Elanco and Novartis Animal Health executive Dr. Jürgen Horn as its new Chief Product Development Officer. Dr. Horn will commence his role at Nexvet in August 2015. Dr. Horn most […]
DUBLIN, Ireland and MELBOURNE, Australia, May 8, 2015 (GLOBE NEWSWIRE) — Veterinary biologic therapy developer Nexvet Biopharma (Nasdaq:NVET) today announced its financial results for the three and nine month periods ended March 31, 2015. Link here. Corporate Highlights In February 2015, we closed our initial public offering of 4.0 million ordinary shares at a price to […]
SEA: NZX MARKET UPDATE 8 May 2015 Link here. SeaDragon appoints Chairman with strong international market expertise SeaDragon, New Zealand’s largest refiner and blender of high quality, fish oils and fractions, including Omega 3 oils, is pleased to announce it has appointed Colin Groves as Chairman. Mr Groves has spent the past 23 years primarily as Director […]
SEA: NZX MARKET UPDATE 4 May 2015. Link here. New Zealand’s largest refiner and blender of high-quality internationally-certified concentrated fish oils and fractions SeaDragon today advises it has begun a transition to new leadership. As foreshadowed at last year’s AGM, SeaDragon Chairman Dr Doug Wilson has advised the company he wishes to stand down from the […]
Link here. Biotechnology entrepreneur brings extensive business development and fundraising expertise to leading bacteriophage-based antibacterials company. San Diego and Richmond, VA, USA, Ljubljana, Slovenia, and Sydney, Australia, April 30, 2015 – AmpliPhi BioSciences Corporation (OTCQB: APHB), a global leader in developing bacteriophage-based antibacterial therapies to treat drug resistant infections, today announced that Scott Salka has been appointed […]
By Nigel Roberts. April 28 2015. Link here. Crispin Simon, chief executive of Rex Bionics (LON:RXB), says the company’s robotic walking device is now attracting the attention of specialist rehabilitation clinics from around the world. ‘Now we do have distribution partners who are expert in the field of neuro-rehabilitation from all over the world who are now coming to […]
Australia, 27 April 2015. Read announcement here.
Australia, 23 April 2015. Read announcement here.
22 April 2015. Link here. Rex Bionics plc, the pioneer of the REX Robot technology that enhances the mobility of wheelchair users and Deltason Medical Ltd, a distributor of rehabilitation equipment in Hong Kong and China, are pleased to announce that they have signed a distribution agreement in which Deltason will exclusively represent REX in Hong […]
Cambridge, 21st April 2015 —Published results from a randomized control clinical trial that used Avita Medical’s skin regenerating device to successfully treat chronic wounds have won the lead clinician the ‘Avita Medical prize for Innovation’, the company announced today…. Read more.